Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

Structure. 2009 Dec 9;17(12):1636-48.

Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.

Chaudhury S, Gray JJ.

Source

Program in Molecular Biophysics, Johns Hopkins University, 3400 N. Charles St. Baltimore, MD 21218, USA.

Abstract

Drug-resistant mutations (DRMs) in HIV-1 protease are a major challenge to antiretroviral therapy. Protease-substrate interactions that are determined to be critical for native selectivity could serve as robust targets for drug design that are immune to DRMs. In order to identify the structural mechanisms of selectivity, we developed a peptide-docking algorithm to predict the atomic structure of protease-substrate complexes and applied it to a large and diverse set of cleavable and noncleavable peptides. Cleavable peptides showed significantly lower energies of interaction than noncleavable peptides with six protease active-site residues playing the most significant role in discrimination. Surprisingly, all six residues correspond to sequence positions associated with drug resistance mutations, demonstrating that the very residues that are responsible for native substrate specificity in HIV-1 protease are altered during its evolution to drug resistance, suggesting that drug resistance and substrate selectivity may share common mechanisms.

PMID:: 20004167; [PubMed - indexed for MEDLINE]
PMCID:: PMC2806847

Free PMC Article

Images from this publication.See all images (7) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, N.I.H., Extramural

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Icon for Elsevier Science

Icon for PubMed Central

Save items

loading

Related citations in PubMed

Review Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. [AIDS Rev. 2008]
Review Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
Lefebvre E, Schiffer CA. AIDS Rev. 2008 Jul-Sep; 10(3):131-42.
Protein promiscuity: drug resistance and native functions--HIV-1 case. [J Biomol Struct Dyn. 2005]
Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A, Tawfik DS, Berkhout B, Sanders R, Kloczkowski A, Sen T, Jernigan B. J Biomol Struct Dyn. 2005 Jun; 22(6):615-24.
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease. [Proteins. 2008]
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
Altman MD, Nalivaika EA, Prabu-Jeyabalan M, Schiffer CA, Tidor B. Proteins. 2008 Feb 15; 70(3):678-94.
Structure-based phenotyping predicts HIV-1 protease inhibitor resistance. [Protein Sci. 2003]
Structure-based phenotyping predicts HIV-1 protease inhibitor resistance.
Shenderovich MD, Kagan RM, Heseltine PN, Ramnarayan K. Protein Sci. 2003 Aug; 12(8):1706-18.
Review Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design. [Curr Drug Targets Infect Disor...]
Review Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.
Velazquez-Campoy A, Muzammil S, Ohtaka H, Schön A, Vega S, Freire E. Curr Drug Targets Infect Disord. 2003 Dec; 3(4):311-28.

See reviews... See all...

Cited by 2 PubMed Central articles

Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity. [PLoS Comput Biol. 2011]
Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity.
London N, Lamphear CL, Hougland JL, Fierke CA, Schueler-Furman O. PLoS Comput Biol. 2011 Oct; 7(10):e1002170. Epub 2011 Oct 6.
Benchmarking and analysis of protein docking performance in Rosetta v3.2. [PLoS One. 2011]
Benchmarking and analysis of protein docking performance in Rosetta v3.2.
Chaudhury S, Berrondo M, Weitzner BD, Muthu P, Bergman H, Gray JJ. PLoS One. 2011; 6(8):e22477. Epub 2011 Aug 2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Identification of structural mechanisms of HIV-1 protease specificity using comp...
Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.
Structure. 2009 Dec 9 ;17(12):1636-48.

PubMed
Those other mammals: the immunoglobulins and T cell receptors of marsupials and ...
Those other mammals: the immunoglobulins and T cell receptors of marsupials and monotremes.
Semin Immunol. 2010 Feb ;22(1):3-9. Epub 2009 Dec 8 .

PubMed
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-...
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation.
Drug Alcohol Depend. 2010 Mar 1 ;107(2-3):261-3. Epub 2009 Dec 9 .

PubMed
Signals for retention of transmembrane proteins in the endoplasmic reticulum stu...
Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants.
Proc Natl Acad Sci U S A. 1991 Mar 1 ;88(5):1918-22.

PubMed
Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomera...
Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence.
Proc Natl Acad Sci U S A. 1991 Mar 1 ;88(5):1903-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk